CXCR3 is the predominant chemokine receptor mediating TE cells recruitment to tumor tissue via its ligands CXCL9 and CXCL10, and has been demonstrated to be crucial for tumor control and survival [36,37]. The gene discussed is CXCL9; the disease is neoplasm.